glp-1 drugs pharmaceutical companies 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Market Industry Trends and

Potential risks : Unknown long-term effects and quality control issues with compounded peptides pose serious concerns

(8) Synergistic Action of Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend The rationale for combining these peptides lies in their supposed distinct mechanisms of action and potential to enhance growth hormone (GH) secretion synergistically

Serious but Less Common Side Effects: Pancreatitis: Although rare, there is a risk of acute pancreatitis

Still, researchers with active malignancy are generally advised to avoid telomerase-activating compounds until more definitive safety data becomes available

Elshorbagy, A